Biogen Inc. (BIIB) Q4 2024 Earnings Call Transcript

Biogen Inc. (NASDAQ:BIIB) Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ET

Company Participants

Tim Power – Head of IR
Chris Viehbacher – President and CEO
Priya Singhal – Head of Development
Mike McDonnell – CFO

Conference Call Participants

Salveen Richter – Goldman Sachs
Michael Yee – Jefferies
Tim Anderson – Bank of America
Brian Abrahams – RBC Capital Markets
Marc Goodman – Leerink
Paul Matteis – Stifel
Umer Raffat – Evercore ISI
Chris Schott – JPMorgan
Evan Seigerman – BMO Capital Markets
Phil Nadeau – TD Cowen

Operator

Good morning. My name is Jennifer and I will be your conference operator today. At this time, I’d like to welcome everyone to the Biogen Fourth Quarter and Full Year 2024 Earnings Call and Business Update. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions]

Today’s conference is being recorded. Thank you. I would now like to turn the conference over to Mr. Tim Power, Head of Investor Relations. Mr. Power, you may begin your conference.

Tim Power

Thanks, Jennifer, and good morning and welcome to Biogen’s fourth quarter and full year 2024 earnings call. During this call, we make forward-looking statements which involves risks and uncertainties that may cause actual results to differ materially from our forward-looking statements. We provide a comprehensive list of risk factors in our SEC filings, which I encourage you to review.

Our earnings release and other documents related to our results, as well as reconciliations between GAAP and non-GAAP results discussed on this call can be found in the Investors section of biogen.com. We’ve also posted slides to our website that we’ll be using during the call. On today’s call, I’m joined by our President and Chief Executive Officer, Chris Viehbacher, Dr. Priya Singhal, Head of